Skip to main content

Table 1 Baseline patient characteristics comparing subjects who did and did not actively consume cannabis products

From: Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis

Demographics Active cannabis users Non-users or previous cannabis users P value
(n = 69) (n = 1762)
aAge (years), mean ± SD 44 ± 19 62 ± 19 < .001
bMale sex, % 62 55 0.219
aBMI (kg/m2), mean ± SD 28.2 ± 7.9 28.8 ± 7.4 0.554
bRace, column %
 White 48% 31% 0.005
 Black 15% 9% 0.136
 Asian 4% 8% 0.362
 Latinx 28% 42% 0.017
 Unknown/mixed race 6% 10% 0.401
bTobacco use, column %
 Never 55% 66% 0.053
 Former use 24.6% 25.4% 1.000
 Current use 20% 4% < .001
 Unknown use 0c% 4% 0.110
bComorbid conditions, column %
 Diabetes mellitus 23% 37% 0.021
 Cardiac disease 16% 24% 0.148
 Chronic kidney disease 17% 27% 0.094
 Chronic pulmonary disease 26% 26% 1.000
 Chronic liver disease 3% 5% 0.581
  1. Active cannabis use defined as cannabis consumption within 1 month of hospitalization. Any cannabis use thereafter are previous users. Non-users are patients with no history of cannabis use
  2. BMI body mass index
  3. aWelch’s t test
  4. bFisher’s exact test
  5. c % of each level of variable within that particular group, not between groups